83 related articles for article (PubMed ID: 16234539)
1. Mafosfamide: a new intra-CSF chemotherapy?
Chamberlain MC
J Clin Oncol; 2005 Oct; 23(30):7748-9; author reply 7749. PubMed ID: 16234539
[No Abstract] [Full Text] [Related]
2. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
Blaney SM; Balis FM; Berg S; Arndt CA; Heideman R; Geyer JR; Packer R; Adamson PC; Jaeckle K; Klenke R; Aikin A; Murphy R; McCully C; Poplack DG
J Clin Oncol; 2005 Mar; 23(7):1555-63. PubMed ID: 15735131
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.
Slavc I; Schuller E; Falger J; Günes M; Pillwein K; Czech T; Dietrich W; Rössler K; Dieckmann K; Prayer D; Hainfellner J
J Neurooncol; 2003 Sep; 64(3):239-47. PubMed ID: 14558599
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.
Slavc I; Schuller E; Czech T; Hainfellner JA; Seidl R; Dieckmann K
J Neurooncol; 1998; 38(2-3):213-8. PubMed ID: 9696374
[TBL] [Abstract][Full Text] [Related]
5. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
Fuchs HE; Archer GE; Colvin OM; Bigner SH; Schuster JM; Fuller GN; Muhlbaier LH; Schold SC; Friedman HS; Bigner DD
Cancer Res; 1990 Mar; 50(6):1954-9. PubMed ID: 2306744
[TBL] [Abstract][Full Text] [Related]
6. 111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik P; Jaeckle KA; Glantz M
Neurology; 1999 Jan; 52(1):216-7. PubMed ID: 9921888
[No Abstract] [Full Text] [Related]
7. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
8. New cytotoxic drugs for intrathecal administration.
Blaney SM; Poplack DG
J Neurooncol; 1998; 38(2-3):219-23. PubMed ID: 9696375
[No Abstract] [Full Text] [Related]
9. Current options for the treatment of neoplastic meningitis.
Cokgor I; Friedman AH; Friedman HS
J Neurooncol; 2002 Oct; 60(1):79-88. PubMed ID: 12416549
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic strategies for the treatment of meningeal malignancy.
Blaney SM; Poplack DG
Invest New Drugs; 1996; 14(1):69-85. PubMed ID: 8880395
[TBL] [Abstract][Full Text] [Related]
11. Neoplastic meningitis: diagnosis and treatment considerations.
Blaney SM; Poplack DG
Med Oncol; 2000 Aug; 17(3):151-62. PubMed ID: 10962524
[TBL] [Abstract][Full Text] [Related]
12. Mafosfamide as a new anticancer agent: preclinical investigations and clinical trials.
Mazur L; Opydo-Chanek M; Stojak M; Wojcieszek K
Anticancer Res; 2012 Jul; 32(7):2783-9. PubMed ID: 22753738
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in neoplastic meningitis.
Pace A; Fabi A
Crit Rev Oncol Hematol; 2006 Dec; 60(3):194-200. PubMed ID: 16949298
[TBL] [Abstract][Full Text] [Related]
14. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
[TBL] [Abstract][Full Text] [Related]
15. [Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer].
Hammerer V; Pauli G; Quoix E
Bull Cancer; 2005 Nov; 92(11):989-94. PubMed ID: 16316833
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
Gururangan S; Petros WP; Poussaint TY; Hancock ML; Phillips PC; Friedman HS; Bomgaars L; Blaney SM; Kun LE; Boyett JM
Clin Cancer Res; 2006 Mar; 12(5):1540-6. PubMed ID: 16533779
[TBL] [Abstract][Full Text] [Related]
17. Neoplastic meningitis.
Johns Hopkins Med J; 1982 Aug; 151(2):59-64. PubMed ID: 6896539
[No Abstract] [Full Text] [Related]
18. N3-methyl-mafosfamide as a chemically stable, alternative prodrug of mafosfamide.
Moon KY; Kwon CH
Bioorg Med Chem Lett; 1998 Jul; 8(13):1673-8. PubMed ID: 9873412
[TBL] [Abstract][Full Text] [Related]
19. [Future prospects].
Soffietti R
Tumori; 2007; 93(3):suppl 14-5. PubMed ID: 17679483
[No Abstract] [Full Text] [Related]
20. Improving the outcome of patients with leptomeningeal cancer: new clinical trials and experimental therapies.
Jaeckle KA
Cancer Treat Res; 2005; 125():181-93. PubMed ID: 16211890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
